oral glp-1 agonist The challenge of developing alternatives to Ozempic, Wegovy and Mounjaro Anesthetic Considerations for Patients Taking

Endocrinology and Metabolism

Liraglutide (Saxenda) was one of the earlier forms of longer-lasting GLP-1s and reduces HbA1c (average blood glucose) levels by around 1.3% on average and fasting plasma glucose by 2 mmol/L

It is typically recommended for individuals who have struggled with obesity and want a reliable, long-term weight management solution

These CVOTs have collectively contributed significantly to our understanding of the cardiovascular outcomes related to GLP-1 receptor agonists

Available as: Last cited 6 Sept 2023 Urva S, OFarrell L, Du Y, Loh MT, Hemmingway A, Qu H, Alsina-Fernandez J, Haupt A, Milicevic Z, Coskun T (2023) The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying